CheezhengTTM released its performance for the first three quarters, with a net profit attributable to the parent company of 424 million yuan, a year-on-year increase of 7.66%Zhitong·Oct 27, 2025 at 08:55 AM002287+0.38%
CheezhengTTM: "Cheezheng Convertible Bonds" have only half a trading day left before trading is suspendedZhitong·Aug 27, 2025 at 11:14 PM002287+0.38%
CheezhengTTM released its performance for the first half of the year, with a net profit attributable to the parent company of 358 million yuan, an increase of 10.04%Zhitong·Aug 22, 2025 at 05:08 AM002287+0.38%
CheezhengTTM: Early redemption of "Cheezheng convertible bonds," reminding investors to convert shares in a timely mannerZhitong·Aug 18, 2025 at 03:06 AM002287+0.38%
CheezhengTTM: The shareholding ratio of the controlling shareholder and its concerted parties has been passively dilutedZhitong·Aug 15, 2025 at 03:36 AM002287+0.38%
CheezhengTTM: Stock trading has fallen more than 20% for two consecutive daysZhitong·Aug 6, 2025 at 04:25 AM002287+0.38%
A-share pharmaceutical stocks continue to adjust, CheezhengTTM approaches the limit down, and multiple stocks such as Xintian Pharmaceutical, Hanyu Pharmaceutical, Guilin Sanjin, Foci Pharmaceutical, YIBAI PHARMACEUTICAL, Zhendong Pharmacy, and Cosunter have fallen over 5%Wallstreetcn·Aug 6, 2025 at 01:41 AM300158+1.44%002287+0.38%
A-shares closing: Three major indices slightly declined, while the pharmaceutical and photovoltaic sectors strengthened against the trendWallstreetcn·Aug 1, 2025 at 02:02 AM600481+1.50%002287+0.38%
The concept of innovative drugs remains active, with Xintian Pharma and others hitting the daily limitZhitong·Jul 31, 2025 at 08:42 PM002287+0.38%600513+3.34%
CheezhengTTM's net profit attributable to the parent company in the first half of the year was 358 million yuan, a year-on-year increase of 9.94%Zhitong·Jul 28, 2025 at 03:44 AM002287+0.38%
CheezhengTTM: Pediatric Re Li Qing Granules clinical trial approvedZhitong·May 28, 2025 at 03:56 AM002287+0.38%
CheezhengTTM released its first-quarter performance, with a net profit attributable to the parent company of 75.6798 million yuan, a year-on-year decrease of 22.35%Zhitong·Apr 24, 2025 at 08:43 AM002287+0.38%
CheezhengTTM plans to spend between 90 million and 160 million yuan to repurchase sharesZhitong·Mar 2, 2025 at 02:13 AM002287+0.38%
CheezhengTTM's net profit for the year 2024 is 575 million yuan, a decrease of 0.98%Zhitong·Feb 27, 2025 at 02:57 AM002287+0.38%
CheezhengTTM disclosed a special dividend plan, proposing a distribution of 2.2 yuan for every 10 sharesZhitong·Dec 30, 2024 at 02:48 AM002287+0.38%
